Darvay A, White I R, Rycroft R J, Jones A B, Hawk J L, McFadden J P
Department of Environmental Dermatology, St John's Institute of Dermatology, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK.
Br J Dermatol. 2001 Oct;145(4):597-601. doi: 10.1046/j.1365-2133.2001.04458.x.
Despite the enormous increase in sunscreen use, allergic contact (AC) and photoallergic (PA) reactions to ultraviolet (UV) filters are considered rare.
To analyse the data from 2715 patients who underwent photopatch testing at St John's Institute of Dermatology during the period 1983-98.
A retrospective analysis of all positive photopatch test episodes was undertaken with the results retrieved from the environmental dermatology database and further verified with the original archived patch test documentation for each individual patient.
In 111 patients with positive reactions (4.1%), there were 155 AC or PA reactions to allergens in the photopatch test series. Eighty PA reactions were observed in 62 (2.3%) patients (32 men and 30 women, age range 28-75 years), with UV filters accounting for 52 positive reactions (65%), drugs 16 (20%), musk ambrette 11 (14%) and the antiseptic trichlorocarbanilide one (1%). The most common UV filter photoallergen was benzophenone-3 with 14 positive results, followed by benzophenone-10 (n = 9), isopropyl dibenzoylmethane (n = 6), p-aminobenzoic acid (PABA) (n = 5), octyl dimethyl PABA (n = 5), butyl methoxydibenzoylmethane (n = 4), isoamyl methoxycinnamate (n = 2), ethyl methoxycinnamate (n = 2), octyl methoxycinnamate (n = 2), amyl dimethyl PABA (n = 2) and phenylbenzimidazole sulphonic acid (n = 1). A similar number of AC reactions to UV filters was detected in this study. Thus 49 patients (1.8%) had a total of 75 reactions: 51 due to UV filters and 24 as a result of exposure to fragrances and therapeutic agents. Benzophenone-10 accounted for 13 AC reactions and benzophenone-3 for eight reactions. Twenty-two patients had a PA reaction alone, whereas 19 patients had chronic actinic dermatitis and 15 patients polymorphic light eruption (PLE) in addition. Thus, 34 of the 62 patients (55%) had a preceding underlying photodermatosis.
These results show a low yield of positive photopatch tests. Thus, despite the large increase in the use of UV filters over the last decade, the development of PA reactions remains rare. Furthermore, most of the common UV filter photoallergens identified in this study, including PABA, amyl dimethyl PABA and benzophenone-10, are now rarely used in sunscreen manufacture, while isopropyl dibenzoylmethane was voluntarily removed from the market in 1993. Currently, benzophenone-3 is the commonest contact photoallergen still in widespread use. In contrast, the UVB filter octyl methoxycinnamate, used in a number of sunscreens, produced only two positive PA reactions in 12 years of testing. Nevertheless, although these reactions are extremely rare, patients with photodermatoses such as PLE and chronic actinic dermatitis do represent a group of patients at increased risk of developing photoallergy. Further photopatch test series should be regularly reviewed and updated, as the relevance of individual photoallergens changes over time. Currently, there is no evidence that PA reactions represent a common clinical problem.
尽管防晒霜的使用量大幅增加,但对紫外线(UV)滤光剂的过敏性接触(AC)和光过敏(PA)反应仍被认为较为罕见。
分析1983年至1998年间在圣约翰皮肤病研究所接受光斑贴试验的2715例患者的数据。
对所有光斑贴试验阳性病例进行回顾性分析,从环境皮肤病数据库中检索结果,并通过每位患者的原始存档斑贴试验记录进一步核实。
在111例反应阳性的患者(4.1%)中,光斑贴试验系列中有155例对过敏原的AC或PA反应。在62例(2.3%)患者(32名男性和30名女性,年龄范围28 - 75岁)中观察到80例PA反应,其中UV滤光剂导致52例阳性反应(65%),药物导致16例(20%),葵子麝香导致11例(14%),防腐剂三氯卡班导致1例(1%)。最常见的UV滤光剂光过敏原是二苯甲酮 - 3,有14例阳性结果,其次是二苯甲酮 - 10(n = 9)、二乙氨羟苯甲酰基苯甲酸己酯(n = 6)、对氨基苯甲酸(PABA)(n = 5)、辛酯二甲基PABA(n = 5)、丁基甲氧基二苯甲酰甲烷(n = 4)、异壬酸异壬酯(n = 2)、甲氧基肉桂酸乙酯(n = 2)、甲氧基肉桂酸辛酯(n = 2)、戊酯二甲基PABA(n = 2)和苯基苯并咪唑磺酸(n = 1)。本研究中检测到对UV滤光剂的AC反应数量相似。因此,49例患者(1.8%)共有75例反应:51例由UV滤光剂引起,24例因接触香料和治疗剂引起。二苯甲酮 - 10导致13例AC反应,二苯甲酮 - 3导致8例反应。22例患者仅有PA反应,而19例患者患有慢性光化性皮炎,15例患者还患有多形性日光疹(PLE)。因此,62例患者中的34例(55%)有先前的潜在光皮肤病。
这些结果表明光斑贴试验阳性率较低。因此,尽管在过去十年中UV滤光剂的使用大幅增加,但PA反应的发生仍然罕见。此外,本研究中确定的大多数常见UV滤光剂光过敏原,包括PABA、戊酯二甲基PABA和二苯甲酮 - 10,现在在防晒霜生产中很少使用,而二乙氨羟苯甲酰基苯甲酸己酯于1993年自愿退出市场。目前,二苯甲酮 - 3是仍在广泛使用的最常见接触性光过敏原。相比之下,许多防晒霜中使用的UVB滤光剂甲氧基肉桂酸辛酯在12年的测试中仅产生了2例阳性PA反应。然而,尽管这些反应极为罕见,但患有PLE和慢性光化性皮炎等光皮肤病的患者确实是发生光过敏风险增加的一组患者。随着个体光过敏原的相关性随时间变化,应定期审查和更新进一步的光斑贴试验系列。目前,没有证据表明PA反应是一个常见的临床问题。